Creative Biosciences

OverviewSuggest Edit

Creative Biosciences (广州市康立明生物科技有限责任) is a biotech company that is engaged in research, development, and manufacture of diagnostic tools for tumors detection. It produces COLOSAFE, a stool DNA methylation testing kit for auxiliary diagnosis of colorectal cancer.
TypePrivate
Founded2015
HQGuangzhou, CN
Websitekangliming.com

Recent NewsAll News

Latest Updates

Cybersecurity ratingAMore

Creative Biosciences Office Locations

Creative Biosciences has an office in Guangzhou
Show all (1)

Creative Biosciences Financials and Metrics

Summary Metrics

Founding Date

2015

Creative Biosciences total Funding

$144 m

Creative Biosciences latest funding size

$88 m

Time since last funding

a year ago

Creative Biosciences investors

Creative Biosciences's latest funding round in September 2020 was reported to be $88 m. In total, Creative Biosciences has raised $144 m
Show all financial metrics

Creative Biosciences Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

Creative Biosciences Online and Social Media Presence

Embed Graph

Creative Biosciences News and Updates

Chinese biotech firm Creative Biosciences raises $88m from IDG, CDH, others

Healthcare-focused private equity firm Tsing Song Capital was the lead investor. The post Chinese biotech firm Creative Biosciences raises $88m from IDG, CDH, others appeared first on DealStreetAsia.

Creative Biosciences Frequently Asked Questions

  • When was Creative Biosciences founded?

    Creative Biosciences was founded in 2015.

  • Who are Creative Biosciences competitors?

    Competitors of Creative Biosciences include Amoy Diagnostics, Check-Cap and Biomedica Molecular Medicine.

  • Where are Creative Biosciences offices?

    Creative Biosciences has an office in Guangzhou.

  • How many offices does Creative Biosciences have?

    Creative Biosciences has 1 office.